Hematologic Malignancies and Cellular Therapy
Leaders in Hematologic Oncology and Stem Cell & Bone Marrow Transplantation
The Duke Division of Hematologic Malignancies & Cellular Therapy is internationally recognized for its novel approaches to treating leukemia, lymphoma, myeloma, and other life threatening diseases through integrated, innovative, and holistic patient care, research, and education.
The mission of the Duke Division of Hematologic Malignancies and Cellular Therapy is to promote health and improve lives by preventing, diagnosing, and treating blood cancer and other life threatening diseases through integrated, innovative, and holistic patient care, education, and research.
Excellence in Patient Care
Our faculty provide comprehensive, multidisciplinary care for patients with hematologic malignancies at the Duke Cancer Center and the Duke Adult Blood & Marrow Transplant Clinic.
Excellence in Research
The Duke Hematologic Malignancies and Cellular Therapy (HMCT) Program is a multidisciplinary basic, translational, and clinical research program whose overall goal is to improve outcomes for patients with hematologic malignancies.
Train with us
The Hematology-Oncology Fellowship program provides clinical and laboratory training in hematology, medical oncology, and bone marrow transplantation.
Wednesday, May 16, 2018
Thursday, May 10, 2018
Friday, April 27, 2018
Monday, April 16, 2018
Monday, March 12, 2018
Tuesday, March 6, 2018